FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980740957> ?p ?o ?g. }

• W1980740957 endingPage "157" @default.
• W1980740957 startingPage "148" @default.
• W1980740957 abstract "To evaluate the imaging features of intrahepatic mass-forming cholangiocarcinomas (IMCCs) at computed tomography (CT), with a special emphasis on the degree and pattern of arterial enhancement, and to determine whether the clinicopathologic features of IMCCs with arterial enhancement differ from those of IMCCs with less arterial enhancement.The institutional review board of Seoul National University Hospital approved this retrospective study, and informed patient consent was waived. Sixty-four patients with 70 pathologically confirmed IMCCs after surgical resection underwent multiphasic CT-unenhanced, hepatic arterial phase (HAP), portal venous phase, and/or equilibrium phase imaging. CT images were retrospectively evaluated for tumor morphology and enhancement features. Patients were placed into typical or atypical enhancement groups according to the presence of enhancement in the largest volume (>50%) of the tumors during the HAP. Imaging features of IMCCs were correlated with pathologic features. The typical and atypical enhancement groups were compared with respect to disease-free survival and overall survival. Survival rates were calculated by using the Kaplan-Meier method, and differences in survival were compared by using the log-rank test. A Cox proportional hazards model was used for multivariate survival analysis.Fifty (71%) of 70 IMCCs showed typical arterial enhancement, and 20 (29%) showed atypical enhancement. The mean diameter of atypical IMCCs was significantly smaller than that of typical IMCCs (P = .001). Chronic liver disease was more frequent in the group with atypical lesions (P = .021). During the HAP, the prevalent enhancement pattern in this group was a mixed pattern of peripheral rim and internal heterogeneous enhancement. At pathologic evaluation, atypically enhancing IMCCs showed less central stroma and necrosis and larger cellular areas and more frequently had a cholangiolocellular component than typically enhancing IMCCs. Arterial enhancement of IMCCs was found to be an independent prognostic factor for longer disease-free survival.Arterially enhancing IMCCs were not rare; thus, enhancement pattern analysis of arterially enhancing IMCCs will be helpful in differentiating them from hepatocellular carcinomas. In addition, arterial enhancement of IMCCs appears to correlate with disease-free survival." @default.
• W1980740957 created "2016-06-24" @default.
• W1980740957 creator A5006136873 @default.
• W1980740957 creator A5017552061 @default.
• W1980740957 creator A5035168521 @default.
• W1980740957 creator A5040976081 @default.
• W1980740957 creator A5049122506 @default.
• W1980740957 creator A5053320499 @default.
• W1980740957 creator A5054880947 @default.
• W1980740957 date "2011-07-01" @default.
• W1980740957 modified "2023-10-14" @default.
• W1980740957 title "Intrahepatic Mass-forming Cholangiocarcinomas: Enhancement Patterns at Multiphasic CT, with Special Emphasis on Arterial Enhancement Pattern—Correlation with Clinicopathologic Findings" @default.
• W1980740957 cites W1970368087 @default.
• W1980740957 cites W1978416394 @default.
• W1980740957 cites W1986373489 @default.
• W1980740957 cites W2005883921 @default.
• W1980740957 cites W2006891464 @default.
• W1980740957 cites W2016436045 @default.
• W1980740957 cites W2042065755 @default.
• W1980740957 cites W2046516836 @default.
• W1980740957 cites W2063725704 @default.
• W1980740957 cites W2066882541 @default.
• W1980740957 cites W2068374657 @default.
• W1980740957 cites W2070666966 @default.
• W1980740957 cites W2078797029 @default.
• W1980740957 cites W2081153690 @default.
• W1980740957 cites W2084440537 @default.
• W1980740957 cites W2089067439 @default.
• W1980740957 cites W2118757896 @default.
• W1980740957 cites W2130207143 @default.
• W1980740957 cites W2130861229 @default.
• W1980740957 cites W2139954808 @default.
• W1980740957 cites W2152360231 @default.
• W1980740957 cites W2152680142 @default.
• W1980740957 cites W2166662741 @default.
• W1980740957 cites W2166888031 @default.
• W1980740957 cites W2168449557 @default.
• W1980740957 cites W4211234270 @default.
• W1980740957 doi "https://doi.org/10.1148/radiol.11101777" @default.
• W1980740957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21474703" @default.
• W1980740957 hasPublicationYear "2011" @default.
• W1980740957 type Work @default.
• W1980740957 sameAs 1980740957 @default.
• W1980740957 citedByCount "195" @default.
• W1980740957 countsByYear W19807409572012 @default.
• W1980740957 countsByYear W19807409572013 @default.
• W1980740957 countsByYear W19807409572014 @default.
• W1980740957 countsByYear W19807409572015 @default.
• W1980740957 countsByYear W19807409572016 @default.
• W1980740957 countsByYear W19807409572017 @default.
• W1980740957 countsByYear W19807409572018 @default.
• W1980740957 countsByYear W19807409572019 @default.
• W1980740957 countsByYear W19807409572020 @default.
• W1980740957 countsByYear W19807409572021 @default.
• W1980740957 countsByYear W19807409572022 @default.
• W1980740957 countsByYear W19807409572023 @default.
• W1980740957 crossrefType "journal-article" @default.
• W1980740957 hasAuthorship W1980740957A5006136873 @default.
• W1980740957 hasAuthorship W1980740957A5017552061 @default.
• W1980740957 hasAuthorship W1980740957A5035168521 @default.
• W1980740957 hasAuthorship W1980740957A5040976081 @default.
• W1980740957 hasAuthorship W1980740957A5049122506 @default.
• W1980740957 hasAuthorship W1980740957A5053320499 @default.
• W1980740957 hasAuthorship W1980740957A5054880947 @default.
• W1980740957 hasBestOaLocation W19807409571 @default.
• W1980740957 hasConcept C126322002 @default.
• W1980740957 hasConcept C126838900 @default.
• W1980740957 hasConcept C141071460 @default.
• W1980740957 hasConcept C142724271 @default.
• W1980740957 hasConcept C167135981 @default.
• W1980740957 hasConcept C2777106319 @default.
• W1980740957 hasConcept C2989005 @default.
• W1980740957 hasConcept C50382708 @default.
• W1980740957 hasConcept C66339696 @default.
• W1980740957 hasConcept C71924100 @default.
• W1980740957 hasConceptScore W1980740957C126322002 @default.
• W1980740957 hasConceptScore W1980740957C126838900 @default.
• W1980740957 hasConceptScore W1980740957C141071460 @default.
• W1980740957 hasConceptScore W1980740957C142724271 @default.
• W1980740957 hasConceptScore W1980740957C167135981 @default.
• W1980740957 hasConceptScore W1980740957C2777106319 @default.
• W1980740957 hasConceptScore W1980740957C2989005 @default.
• W1980740957 hasConceptScore W1980740957C50382708 @default.
• W1980740957 hasConceptScore W1980740957C66339696 @default.
• W1980740957 hasConceptScore W1980740957C71924100 @default.
• W1980740957 hasIssue "1" @default.
• W1980740957 hasLocation W19807409571 @default.
• W1980740957 hasLocation W19807409572 @default.
• W1980740957 hasOpenAccess W1980740957 @default.
• W1980740957 hasPrimaryLocation W19807409571 @default.
• W1980740957 hasRelatedWork W1554732404 @default.
• W1980740957 hasRelatedWork W1968524627 @default.
• W1980740957 hasRelatedWork W2214928730 @default.
• W1980740957 hasRelatedWork W2360780628 @default.
• W1980740957 hasRelatedWork W2399559262 @default.
• W1980740957 hasRelatedWork W2604243480 @default.
• W1980740957 hasRelatedWork W2732750475 @default.
• W1980740957 hasRelatedWork W3136232645 @default.

• next